Global Epigenomics Industry Research Report 2023-2031: How Epigenomics Is Shaping the Future of Personalized Medicine and Cancer Treatment - Market Set to Surge with Growing Government Funding
Tuesday, October 10, 2023
DUBLIN, Oct. 2, 2023 /PRNewswire/ -- The "Global Epigenomics Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The global epigenomics market value is anticipated to grow at a CAGR of 13.1% during the forecast period of 2023-2031.
Epigenomics, a dynamic field of study, explores alterations in gene expression triggered by modifications to the DNA molecule itself, rather than changes in the DNA sequence. These modifications possess the remarkable ability to transcend generations and can be influenced by environmental factors like dietary choices, toxins, and stressors. The burgeoning realm of epigenomics holds tremendous potential to reshape disease diagnosis and treatment paradigms.
While the integration of epigenomics into healthcare remains relatively novel, it harbors the potential to enrich our comprehension of disease mechanisms, paving the way for more personalized and efficacious treatments. Epigenomic research has already birthed novel cancer therapies and unveiled valuable disease biomarkers for diagnosis and prognosis.
As this field continues to flourish, interest burgeons in crafting epigenetic interventions for diverse maladies, encompassing cancer, autoimmune ailments, and neurological disorders. Simultaneously, there's a pressing need for advancing epigenetic technologies and methodologies, making them more accessible and cost-effective.
In summation, the realm of epigenomics holds immense promise for augmenting our grasp of diseases and their treatments, promising to be a pivotal arena of ongoing research and development.
Epigenomics Market Landscape
Epigenomics, a branch of science delving into the interplay between genes and the environment, can trigger gene activation or deactivation, consequently influencing health and disease outcomes. This domain scrutinizes DNA and histone protein modifications that govern gene expression, all without altering the fundamental genetic code. Epigenomic insights are gaining prominence in comprehending the origins of ailments like cancer, Alzheimer's, and diabetes, among others.
Forecasts predict substantial growth in the global epigenomics market, underpinned by factors such as augmented government funding for epigenomics research, surging incidences of cancer and chronic ailments, and surging demand for personalized healthcare. Furthermore, technological strides in epigenomic methodologies, encompassing next-gen sequencing, mass spectrometry, and bioinformatics tools, are set to further fuel market expansion.
North America is poised to claim the lion's share of the global epigenomics market, closely trailed by Europe and the Asia-Pacific region. The North American market benefits from the presence of key industry players, augmented government backing for epigenomics research, and the escalating prevalence of chronic conditions like cancer and diabetes.
The Asia-Pacific zone is poised for substantial growth, buoyed by government initiatives that bolster research and development endeavors, burgeoning healthcare infrastructure, and rising healthcare expenditure across the region.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
Key Trends in the Epigenomics Market
-- Rising demand for personalized medicine: The growing awareness about
personalized medicine is driving the growth of the Epigenomics market.
Epigenomics offers a wide range of applications in the field of
personalized medicine such as early detection, diagnosis, prognosis, and
treatment of diseases
-- Increasing prevalence of cancer and other chronic diseases: The
increasing prevalence of cancer and other chronic diseases is driving
the demand for Epigenomics technologies. Epigenetic modifications play a
crucial role in the development and progression of cancer and other
chronic diseases, making it a promising tool for diagnosis, prognosis,
and treatment of these diseases
-- Technological advancements: The development of advanced technologies in
Epigenomics such as next-generation sequencing, DNA methylation
analysis, histone modification analysis, and ChIP sequencing is driving
the growth of the market. These advanced technologies offer high
accuracy, sensitivity, and specificity, making them an ideal tool for
Epigenomics research
-- Government initiatives and funding: The governments of various countries
are investing heavily in Epigenomics research and development, which is
driving the growth of the market. For instance, the National Institutes
of Health (NIH) has launched various programs and initiatives to promote
Epigenomics research and development
-- Growing collaborations and partnerships: The increasing collaborations
and partnerships among key players in the market are driving the growth
of the Epigenomics market. The collaborations and partnerships are aimed
at developing new products and technologies, expanding the product
portfolio, and increasing the market share of the companies.
Epigenomics Market: Competitor Landscape
-- Epigenomics AG
-- Illumina, Inc
-- Merck KGaA
-- Zymo Research Corporation
-- Agilent Technologies, Inc.
Epigenomics Market Segmentations
Market Breakup by Technology
-- Histone Methylation
-- Large Non-Coding RNA
-- MicroRNA Modification
-- DNA Methylation
-- Chromatin Structures
-- Others
Market Breakup by Product Type
-- Kits
-- Reagents
-- Enzymes
-- Others
Market Breakup by Application
-- Diagnostics
-- Pharmaceuticals
Market Breakup by End User
-- Hospitals and Clinics
-- Pharmaceuticals and Biotechnology Company
Market Breakup by Region
North America
-- United States of America
-- Canada
Europe
-- United Kingdom
-- Germany
-- France
-- Italy
-- Others
Asia Pacific
-- China
-- Japan
-- India
-- ASEAN
-- Australia
-- Others
Latin America
-- Brazil
-- Argentina
-- Mexico
-- Others
Middle East and Africa
-- Saudi Arabia
-- United Arab Emirates
-- Nigeria
-- South Africa
-- Others
For more information about this report visit https://www.researchandmarkets.com/r/x550ka
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-epigenomics-industry-research-report-2023-2031-how-epigenomics-is-shaping-the-future-of-personalized-medicine-and-cancer-treatment---market-set-to-surge-with-growing-government-funding-301944291.html
SOURCE Research and Markets
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
|
